Edition:
India

Blueprint Medicines Submits New Drug Application For Avapritinib


Friday, 14 Jun 2019 

June 14 (Reuters) - Blueprint Medicines Corp ::BLUEPRINT MEDICINES SUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR AVAPRITINIB FOR THE TREATMENT OF PDGFRA EXON 18 MUTANT GIST AND FOURTH-LINE GIST.BLUEPRINT MEDICINES CORP - HAS REQUESTED PRIORITY REVIEW FOR APPLICATION. 

Company Quote

76.2
-2.48 -3.15%
11:37pm IST